Authors: MASELLIS M BASILE V MELTZER HY LIEBERMAN JA SEVY S MACCIARDI FM COLA P HOWARD A BADRI F NOTHEN MM KALOW W KENNEDY JL

Citation: M. Masellis et al., SEROTONIN SUBTYPE-2 RECEPTOR GENES AND CLINICAL-RESPONSE TO CLOZAPINEIN SCHIZOPHRENIA-PATIENTS, Neuropsychopharmacology, 19(2), 1998, pp. 123-132

Authors: SEVY S DAVIDSON M

Citation: S. Sevy et M. Davidson, THE COST OF COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA, Schizophrenia research, 17(1), 1995, pp. 1-3

Authors: MENDELBAUM K SEVY S SOUERY D PAPADIMITRIOU GN DEBRUYN A RAEYMAEKERS P VANBROECKHOVEN C MENDLEWICZ J

Citation: K. Mendelbaum et al., MANIC-DEPRESSIVE ILLNESS AND LINKAGE REANALYSIS IN THE XQ27-XQ28 REGION OF CHROMOSOME-X, Neuropsychobiology, 31(2), 1995, pp. 58-63

Authors: EPSTEIN JI KAHN RS MACALUSO JM SEVY S HIRSHOWITZ J DAVIDSON M

Citation: Ji. Epstein et al., DOPAMINE AGONIST TREATMENT IN SCHIZOPHRENIA, Schizophrenia research, 11(2), 1994, pp. 108-108

Authors: SEVY S BROWN SL WETZLER S KOTLER M MOLCHO A PLUTCHIK R VANPRAAG HM

Citation: S. Sevy et al., EFFECTS OF ALPRAZOLAM ON INCREASES IN HORMONAL AND ANXIETY LEVELS INDUCED BY META-CHLOROPHENYLPIPERAZINE, Psychiatry research, 53(3), 1994, pp. 219-229

Authors: KAHN RS DAVIDSON M SIEVER LJ SEVY S DAVIS KL

Citation: Rs. Kahn et al., CLOZAPINE TREATMENT AND ITS EFFECT ON NEUROENDOCRINE RESPONSES INDUCED BY THE SEROTONIN AGONIST, M-CHLOROPHENYLPIPERAZINE, Biological psychiatry, 35(12), 1994, pp. 909-912